Affiliation:
1. Department of Practice, Sciences, and Health Outcomes Research University of Maryland School of Pharmacy Rockville Maryland USA
2. Department of Pharmacy Practice Texas Tech University Health Sciences Center Lubbock Texas USA
Abstract
AbstractCannabis is a plant that has been grown for centuries for it is industrial, medicinal, and recreational uses. Over the last few decades, cannabis has been increasingly used therapeutically and recreationally as states increasingly decriminalize or legalize its cultivation and sale. Pharmacists, as medication experts, can play an important role in educating patients and other healthcare professionals about cannabis, the evidence of its potential for therapeutic use, and the risks for short and long‐term adverse effects. This paper aims to broadly review the current policy landscape, describe specific issues and challenges relevant to patients and healthcare providers, and provide a framework for the clinical pharmacist's approach to the patient using cannabis.
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacy
Reference76 articles.
1. Commissioner Oof the. FDA and cannabis: Research and Drug Approval Process [Internet]. U.S. Food and Drug Administration. FDA. [cited 2022 Nov 7]. Available from:https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process#:~:text=The%20agency%20has%2C%20however%2C%20approved %2C%20and%20Cesamet%20(nabilone)
2. Karmen HansonAG.[Internet]. State Medical Cannabis Laws. [cited 2022 Nov 7]. Available from:https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspxrch.2018.12.011